VOLV GLOBAL

inTrigue is a new way of building computational models using machine learning to detect undiagnosed rare disease patients in population-scale databases such as electronic health records. Volv has a number of ancillary products that together with the core predictive modelling make up the inTrigue methodology. The ancillary products and services enrich the insights and learnings derived from the core predictive modelling delivering further value to patients, healthcare providers and payers alike.... Volv was founded to enable customers and partners to achieve better business and clinical outcomes from insights derived from diverse data sets, by taking advantage of the latest developments in technology and data science that Volv has brought to market. Volv’s mission is to speed science, reduce the cost of healthcare, and so enhance the economic output and well-being for all. The purpose of the company is: to design, develop, produce, promote, market and supply high-tech products and services in Switzerland and abroad using artificial intelligence and machine learning technologies; the purchase, holding and management of property of any kind as well as the acquisition of equity interests, with the exclusion of transactions prohibited by the LFAIE; the possession and use of patents, licenses, trademarks, know-how and any other kind of intellectual property rights.More